Suchergebnisse - "Carpano, Silvia"

PubPharm (45)

1

A real-world multicentre evaluation of atezolizumab plus platinum-etoposide chemotherapy as first-line treatment in patients with extensive-stage small cell lung cancer in Italy

enthalten in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | 2024

von Musicco, F. | Fulgenzio, C. | Malfa, A. | +13

2

Tumoral and stromal hMENA isoforms impact tertiary lymphoid structure localization in lung cancer and predict immune checkpoint blockade response in patients with cancer

enthalten in: EBioMedicine | 2024

von Di Modugno, F. | Di Carlo, A. | Spada, S. | +28

3

Activated MKK3/MYC crosstalk impairs dabrafenib response in BRAFV600E colorectal cancer leading to resistance

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2023

von Pranteda, A. | Piastra, V. | Serra, M. | +8

4

Guideline-Based Follow-Up Outcomes in Patients With Gastrointestinal Stromal Tumor With Low Risk of Recurrence : A Report From the Italian Sarcoma Group

enthalten in: JAMA network open | 2023

von D'Ambrosio, L. | Fumagalli, E. | De Pas, T. | +32

ErratumIn: JAMA Netw Open. 2024 Jan 2;7(1):e2354891. - PMID 38231516

5

hMENA isoforms regulate cancer intrinsic type I IFN signaling and extrinsic mechanisms of resistance to immune checkpoint blockade in NSCLC

enthalten in: Journal for immunotherapy of cancer | 2023

von Trono, P. | Tocci, A. | Palermo, B. | +21

6

Pretreated EGFRdel19/BRAFV600E Lung Adenocarcinoma With Leptomeningeal Disease Achieving Long-Lasting Disease Control on Osimertinib, Dabrafenib, and Trametinib : A Case Report

enthalten in: JTO clinical and research reports | 2023

von Orciuolo, C. | Cappuzzo, F. | Landi, L. | +7

7

Correction to : Prognostic value of total metabolic tumour volume and therapy-response assessment by [18F]FDG PET/CT in patients with metastatic melanoma treated with BRAF/MEK inhibitors

enthalten in: European radiology | 2022

von Annovazzi, A. | Ferraresi, V. | Rea, S. | +4

ErratumFor: Eur Radiol. 2022 May;32(5):3398-3407. - PMID 34779873

8

Prognostic value of total metabolic tumour volume and therapy-response assessment by [18F]FDG PET/CT in patients with metastatic melanoma treated with BRAF/MEK inhibitors

enthalten in: European radiology | 2022

von Annovazzi, A. | Ferraresi, V. | Rea, S. | +4

ErratumIn: Eur Radiol. 2022 Mar 9;:. - PMID 35262771

9

Correction to: Prognostic value of total metabolic tumour volume and therapy-response assessment by [18F]FDG PET/CT in patients with metastatic melanoma treated with BRAF/MEK inhibitors

enthalten in: European radiology | 2022

von Annovazzi, A. | Ferraresi, V. | Rea, S. | +4

10

Immunotherapy with nivolumab and pembrolizumab in unresectable or metastatic advanced melanoma : real-life observational study of drug use.

enthalten in: Recenti progressi in medicina | 2021

von Musicco, F. | Fulgenzio, C. | La Malfa, A. | +4

1
2
3
4
5
Nächster »
[5]